ArticleTurkish journal of medical sciences2019

Mid-dose losartan mitigates diabetes-induced hepatic damage by regulating iNOS, eNOS, VEGF, and NF-κB expressions

Fatih Oltulu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.